MIPEP recessive variants cause a syndrome of left ventricular non-compaction, hypotonia, and infantile death

Abstract

BackgroundMitochondrial presequence proteases perform fundamental functions as they process about 70 % of all mitochondrial preproteins that are encoded in the nucleus and imported posttranslationally. The mitochondrial intermediate presequence protease MIP/Oct1, which carries out precursor processing, has not yet been established to have a role in human disease.MethodsWhole exome sequencing was performed on four unrelated probands with left ventricular non-compaction (LVNC), developmental delay (DD), seizures, and severe hypotonia. Proposed pathogenic variants were confirmed by Sanger sequencing or array comparative genomic hybridization. Functional analysis of the identified MIP variants was performed using the model organism Saccharomyces cerevisiae as the protein and its functions are highly conserved from yeast to human.ResultsBiallelic single nucleotide variants (SNVs) or copy number variants (CNVs) in MIPEP, which encodes MIP, were present in all four probands, three of whom had infantile/childhood death. Two patients had compound heterozygous SNVs (p.L582R/p.L71Q and p.E602*/p.L306F) and one patient from a consanguineous family had a homozygous SNV (p.K343E). The fourth patient, identified through the GeneMatcher tool, a part of the Matchmaker Exchange Project, was found to have inherited a paternal SNV (p.H512D) and a maternal CNV (1.4-Mb deletion of 13q12.12) that includes MIPEP. All amino acids affected in the patients’ missense variants are highly conserved from yeast to human and therefore S. cerevisiae was employed for functional analysis (for p.L71Q, p.L306F, and p.K343E). The mutations p.L339F (human p.L306F) and p.K376E (human p.K343E) resulted in a severe decrease of Oct1 protease activity and accumulation of non-processed Oct1 substrates and consequently impaired viability under respiratory growth conditions. The p.L83Q (human p.L71Q) failed to localize to the mitochondria.ConclusionsOur findings reveal for the first time the role of the mitochondrial intermediate peptidase in human disease. Loss of MIP function results in a syndrome which consists of LVNC, DD, seizures, hypotonia, and cataracts. Our approach highlights the power of data exchange and the importance of an interrelationship between clinical and research efforts for disease gene discovery.Electronic supplementary materialThe online version of this article (doi:10.1186/s13073-016-0360-6) contains supplementary material, which is available to authorized users.

A Versatile Sample Processing Workflow for Metagenomic Pathogen Detection

“…However, for various matrices and matrix-pathogen combinations, established and validated protocols are missing. Previous diagnostic metagenomics studies dealt with selected sample types (e.g., stool 16 , 17 ; intraocular fluids 18 ) or were focused to specific pathogen groups (viruses, bacteria, or parasites). Therefore, the improvement and harmonization of pathogen-independent metagenomics to be used in human and animal health and food safety 19 , 20 is necessary.…”

Transplantation of wild-type mouse hematopoietic stem and progenitor cells ameliorates deficits in a mouse model of Friedreich’s ataxia

“…In contrast, very few changes in expression were identified between wild-type mice and HSPC-transplanted YG8R mice (four genes), and none was identified with a significant difference. Among the significantly up-regulated genes in YG8R mice versus wild-type mice, there were 25 genes from the solute mitochondrial carrier protein family ( P < 0.05) (48), including Mipep , an important component of the human mitochondrial import machinery implicated in developmental delay (49), and the fatty acid transporter Cpt1b , which is up-regulated in posttraumatic stress disorder (50). …”

Mitochondrial diseases: expanding the diagnosis in the era of genetic testing

“…MIPEP encodes a peptidase that is required for secondary processing within the matrix. Variants in this gene has been found in patients with cardiomyopathy, developmental delay, seizures, and early death [203] . PMPCA encodes the alpha subunit of the mitochondrial precursor peptidase, the primary enzyme responsible for the maturation of most of the nuclear-encoded proteins entering into the matrix [204] .…”